• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保守性手术分期作为无性细胞瘤患者保留生育能力的一种手段:病例报告。

Conservative surgical staging as a means to preserve fertility in patients with dysgerminoma: a case report.

作者信息

Maidarti Mila, Garinasih Prini D, Anggraeni Tricia D

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynaecology, Faculty of Medicine, Universitas Indonesia.

Yasmin IVF Clinic, Dr. Cipto Mangunkusumo General Hospital.

出版信息

Ann Med Surg (Lond). 2023 Feb 13;85(3):427-430. doi: 10.1097/MS9.0000000000000146. eCollection 2023 Mar.

DOI:10.1097/MS9.0000000000000146
PMID:36923762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10010807/
Abstract

UNLABELLED

Ovarian tumor is a rare condition in pediatrics. Due to the improvement in surgical techniques and chemotherapy in recent years, it is currently possible to preserve fertility in selected cases of patients who desire motherhood.

CASE PRESENTATION

We present a case of pregnancy following conservative surgery and complete chemotherapy for ovarian dysgerminoma stage IIA. A 16-year-old female presented with complaints of abdominal mass and discomfort. Histopathological examination displayed dysgerminoma arising from the right ovary. Conservative treatment with right salpingo-oophorectomy and six cycles of chemotherapy was performed. Within 2 years following the surgery, the patient conceived and did not indicate tumor recurrence.

CLINICAL DISCUSSION

Dysgerminoma is the most common ovarian malignant germ cell tumor and usually affects women at a young age. Conservative surgery followed by chemotherapy is the treatment of choice, particularly in young patients with a strong desire to have a family. Conservative fertility-sparing surgery does not have inferior outcomes in terms of survival or recurrence. It is possible that in certain cases, patients previously treated for ovarian cancer may retain their fertility, thereby improving their quality of life.

CONCLUSION

Most patients with dysgerminoma can be treated with the maintenance of normal reproductive function. Reassurance regarding the high probability of conceiving and having normal children after conservative surgery and chemotherapy should be informed to the patient and family.

摘要

未标注

卵巢肿瘤在儿科是一种罕见病症。由于近年来手术技术和化疗的进步,目前在某些有生育意愿的患者中保留生育能力成为可能。

病例报告

我们报告一例卵巢无性细胞瘤IIA期患者在接受保守手术及完整化疗后怀孕的病例。一名16岁女性因腹部肿块和不适前来就诊。组织病理学检查显示肿瘤起源于右侧卵巢,为无性细胞瘤。对其实施了右侧输卵管卵巢切除术及六个周期的化疗进行保守治疗。术后两年内,该患者成功受孕且未出现肿瘤复发迹象。

临床讨论

无性细胞瘤是最常见的卵巢恶性生殖细胞肿瘤,通常影响年轻女性。首选治疗方法是保守手术联合化疗,尤其是对于有强烈生育意愿的年轻患者。保留生育功能的保守手术在生存率和复发率方面并无劣势。在某些情况下,先前接受过卵巢癌治疗的患者有可能保留生育能力,从而提高生活质量。

结论

大多数无性细胞瘤患者可以在维持正常生殖功能的情况下接受治疗。应告知患者及其家属,保守手术和化疗后成功受孕并生育正常孩子的可能性很大,以此给予他们安心。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/10010807/5e1d651f2cd2/ms9-85-456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/10010807/5e1d651f2cd2/ms9-85-456-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1a0/10010807/5e1d651f2cd2/ms9-85-456-g001.jpg

相似文献

1
Conservative surgical staging as a means to preserve fertility in patients with dysgerminoma: a case report.保守性手术分期作为无性细胞瘤患者保留生育能力的一种手段:病例报告。
Ann Med Surg (Lond). 2023 Feb 13;85(3):427-430. doi: 10.1097/MS9.0000000000000146. eCollection 2023 Mar.
2
[Successful pregnancy after conservative surgery and chemotherapy for dysgerminoma of the ovary: case report].[卵巢无性细胞瘤经保守性手术及化疗后成功妊娠:病例报告]
Ginekol Pol. 1999 Aug;70(8):553-7.
3
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.交界性卵巢肿瘤:法国 CNGOF 指南。第 2 部分。手术管理、随访、激素替代治疗、生育管理和保存。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101966. doi: 10.1016/j.jogoh.2020.101966. Epub 2020 Nov 2.
4
Ovarian dysgerminoma in pregnancy: A case report and literature review.妊娠性卵巢未成熟畸胎瘤:病例报告及文献复习。
Cancer Biol Ther. 2018 Aug 3;19(8):649-658. doi: 10.1080/15384047.2018.1450118. Epub 2018 Apr 25.
5
Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary.卵巢生殖细胞肿瘤保守性手术后的生育能力和卵巢功能
Aust N Z J Obstet Gynaecol. 1999 May;39(2):243-5. doi: 10.1111/j.1479-828x.1999.tb03382.x.
6
Current therapy for dysgerminoma of the ovary.卵巢无性细胞瘤的当前治疗方法。
Obstet Gynecol. 1987 Aug;70(2):268-75.
7
Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.Ⅰ期单纯未成熟型卵巢畸胎瘤患者行保留生育功能手术后行分期手术和辅助化疗的作用。
Int J Gynecol Cancer. 2020 May;30(5):664-669. doi: 10.1136/ijgc-2019-001116. Epub 2020 Mar 15.
8
Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.卵巢无性细胞瘤化疗后的结局及生殖功能
J Clin Oncol. 1999 Sep;17(9):2670-75. doi: 10.1200/JCO.1999.17.9.2670.
9
Pure dysgerminoma of the ovary: a single institutional experience of 65 patients.单纯型卵巢生殖细胞瘤 65 例单中心经验
Med Oncol. 2012 Dec;29(4):2944-8. doi: 10.1007/s12032-012-0194-z. Epub 2012 Mar 10.
10
Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.保留生育功能手术应成为恶性卵巢生殖细胞肿瘤患者的标准治疗方法。
J Adolesc Young Adult Oncol. 2017 Jun;6(2):270-276. doi: 10.1089/jayao.2016.0086. Epub 2017 Jan 13.

引用本文的文献

1
Spontaneous pregnancy after fertility-sparing surgery and adjuvant chemotherapy for advanced pure dysgerminoma: A case report.晚期纯无性细胞瘤保留生育功能手术后联合辅助化疗后自然受孕:一例报告
Clin Case Rep. 2024 May 30;12(6):e9020. doi: 10.1002/ccr3.9020. eCollection 2024 Jun.
2
Yolk Sac Tumor of the Ovary in Mosaic 46XX Turner Syndrome.嵌合型46XX特纳综合征中的卵巢卵黄囊瘤
Int J Womens Health. 2024 Apr 16;16:629-635. doi: 10.2147/IJWH.S462375. eCollection 2024.

本文引用的文献

1
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.卵巢癌临床实践指南(2020 年第 2 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007.
2
The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.SCARE 2020 指南:更新共识手术病例报告(SCARE)指南。
Int J Surg. 2020 Dec;84:226-230. doi: 10.1016/j.ijsu.2020.10.034. Epub 2020 Nov 9.
3
Germ Cell Tumors of the Female Genital Tract.女性生殖道生殖细胞肿瘤
Surg Pathol Clin. 2019 Jun;12(2):621-649. doi: 10.1016/j.path.2019.01.005.
4
Fertility management for malignant ovarian germ cell tumors patients.恶性卵巢生殖细胞肿瘤患者的生育力管理。
Crit Rev Oncol Hematol. 2017 Dec;120:34-42. doi: 10.1016/j.critrevonc.2017.10.005. Epub 2017 Oct 16.
5
Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.保留生育功能手术应成为恶性卵巢生殖细胞肿瘤患者的标准治疗方法。
J Adolesc Young Adult Oncol. 2017 Jun;6(2):270-276. doi: 10.1089/jayao.2016.0086. Epub 2017 Jan 13.
6
The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells.化疗药物对卵巢卵泡和颗粒细胞的性腺毒性程度因药物类别和颗粒细胞类型而异。
Hum Reprod. 2015 Dec;30(12):2926-35. doi: 10.1093/humrep/dev256. Epub 2015 Oct 13.
7
Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II.乳腺癌患者对治疗的恐惧:多中心纵向研究BRENDA II的结果
Breast Care (Basel). 2015 Apr;10(2):95-100. doi: 10.1159/000381933.
8
Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults.癌症治疗与性腺功能:儿童和青年癌症患者生育力保存的实验与临床策略。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):556-67. doi: 10.1016/S2213-8587(15)00039-X. Epub 2015 Apr 12.
9
Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.化疗诱导的人类卵巢衰老机制:双链DNA断裂与微血管损伤。
Aging (Albany NY). 2011 Aug;3(8):782-93. doi: 10.18632/aging.100363.
10
Indications and teaching of fertility preservation in the surgical management of gynecologic malignancies: European perspective.
Gynecol Oncol. 2009 Aug;114(2 Suppl):S32-6. doi: 10.1016/j.ygyno.2009.04.010.